drugset / Trial / NCT02752334

Magnesium Sulphate in the Ultrasound-guided Supraclavicular Brachial Plexus Block

NCT02752334

Phase 2 Completed 60 enrolled Magrabi Eye & Ear Hospital
RandomizedParallel-groupDouble-blindDiagnostic

Summary

This study evaluated the motor and sensory block duration and the postoperative analgesic effects of adding Magnesium Sulphate to bupivacaine in the ultrasound-guided supraclavicular brachial plexus block Anesthesia. Motor and sensory block duration were considered as a primary endpoint.

Timeline

Start
2015-09
Primary completion
2019-02
Completion
2019-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 100 mg Other

Indications

No indication recorded.